Bahareh (Spring) Behrouz, PhD
CEO at NeuroInitiative, LLC
Location: Jacksonville, Florida, United States
Bahareh (Spring) Behrouz, PhD, is the CEO of NeuroInitiative, LLC, a small biotech company she co-founded in 2014. The focus of her research is the elucidation of converging pathways that contribute to the pathogenesis of Parkinsonís disease (PD). The company currently employs a proprietary computational simulation program to create in silico models of PD as a platform to test potential therapeutic targets.
Dr. Behrouz received her graduate training at Michigan State University in the laboratory of Dr. John Goudreau and studied differential susceptibility of dopaminergic neuron subtypes in models of PD. She completed her post-doctoral training in the laboratory of Dr. Matthew Farrer at the Mayo Clinic in Jacksonville, where she primarily focused on in vivo and primary culture models of LRRK2-mediated pathogenesis.